Skip to main content
Log in

Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: A preliminary report

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

With the aim of minimizing postoperative liver dysfunction and promoting increased resectability, we employed portal vein embolization (PVE). In this study, the effect of PVE on major hepatic resection for advanced-stage hepatocellular carcinoma (HCC) in injured livers was evaluated. PVE was performed prior to hepatectomy in 13 patients with stage III and IV HCCs. Following PVE, right trisegmentectomy was performed in 3 patients, extended right lobectomy in 3 and right lobectomy in 7. To evaluate the effect of PVE, the changes in liver functional capacity and estimated remnant liver volume (ERLV), determined by computed tomography, were examined before and after PVE. The operative morbility, mortality, and survival rates after hepatectomy were also assessed. By 2 weeks after PVE, ERLV had increased in all patients, by an average of 28%, and the mean resection rates had decreased from 70.0% to 62.2%. Postoperatively, the 30-day mortality rate was 15.3%, and the 1- and 2-year survival rates were 69% and 46%, respectively. The results of this study indicate that resectability can be increased, and major hepatectomy can be made safer by employing PVE preoperatively, in view of the fact that major hepatectomy was not considered feasible without PVE in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, Furukawa K, Tanaka T, Tomoda F, Tanaka W (1993) Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 18:79–85

    Article  CAS  PubMed  Google Scholar 

  2. Kawasaki S, Makuuti M, Miyagawa S, Kakazu T, Hayashi K, Kasai H, Miwa S, Hui AM, Nishimaki K (1995) Results of hepatic resection for hepatocellular carcinoma. World J Surg 19:31–34

    Article  CAS  PubMed  Google Scholar 

  3. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K (1984) Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impared hepatic function. Surgery 95:586–592

    CAS  PubMed  Google Scholar 

  4. Nagasue N, Ykaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K (1986) Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 99:694–702

    CAS  PubMed  Google Scholar 

  5. Hermanek P, Sobin LH (1987) TMN classification of malignant tumors. 4th edn. Springer, Berlin, Heidelberg, New York, London, Paris, Tokyo

    Google Scholar 

  6. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Guven P, Yamazaki S, Hasegawa H, Ozaki H (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 107:521–527

    CAS  PubMed  Google Scholar 

  7. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10:803–808

    Article  CAS  PubMed  Google Scholar 

  8. Tanabe M, Tamai T, Mimura H, Orita K, Tsumure M, Mizukawa K, Satoh K, Kojima K, Ohkawa M, Takashima H, Hino I, Kawase Y, Seo H, Hosokawa N, Matsuno S, Miyamoto T (1989) Clinical values for an index predicting postoperative residual liver function by pre-operative liver-scintigraphy in patients with liver discase. Ann Nucl Med 3:25–29

    CAS  PubMed  Google Scholar 

  9. Ohto M, Yoshikawa M, Saisho H, Ebara M, Sugiura N (1995) Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients. World J Surg 19:42–46

    Article  CAS  PubMed  Google Scholar 

  10. Colombo M (1993) Hepatocellular carcinoma in cirrhosis. Semin Liver Dis 13:374–383

    CAS  PubMed  Google Scholar 

  11. Ohto M, Kondo F, Ebara M (1992) Pathology, diagnosis and treatment of small liver cancer. In: Tobe T, Kaneda H, Okudaira M, Ohto M, Endo Y, Mito M, Okamoto E, Tanikawa K, Kojiro M (eds) Primary liver cancer in Japan. Springer, Berlin Heidelberg New York Tokyo, pp 365–373

    Google Scholar 

  12. The Liver Cancer Study Group of Japan (1984) Primary liver cancer in Japan. Cancer 54:1747–1755

    Google Scholar 

  13. Kinami Y, Takashima S, Miyazaki I (1986) Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis. World J Surg 10:294–301

    Article  CAS  PubMed  Google Scholar 

  14. Farmer DG, Rosove M, Shaked A, Busuttil RW (1994) Current treatment modalities for hepatocellular carcinoma. Ann Surg 219:236–247

    CAS  PubMed  Google Scholar 

  15. Lin TY, Lee CS, Chen CC, Liau KY, Lin WSJ (1979) Regeneration of human liver after hepatic lobectomy studied by repeated liver scanning and repeated needle biopsy. Ann Surg 190:48–53

    CAS  PubMed  Google Scholar 

  16. Kawasaki S, Makuuti M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, Sugihara K, Moriya Y (1994) Resection of multiple metastatic liver tumors after portal embolization. Surgery 115:674–677

    CAS  PubMed  Google Scholar 

  17. Tsao JI, Loftus JP, Nagorney DM, Adson MA, Iistrup DM (1994) Trends in morbidity and mortality of hepatic resection for malignancy. Ann Surg 220:199–205

    CAS  PubMed  Google Scholar 

  18. Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, Tanaka T, Tomoda F (1994) A prediction scoring system to select the surgical treatment of liver cancer. Ann Surg 219:342–346

    CAS  PubMed  Google Scholar 

  19. Nagao T, Goto S, Kawano N, Inoue S, Mizuta T, Morioka Y, Omori Y (1987) Hepatic resection for hepatocellular carcinoma. Ann Surg 205:33–40

    CAS  PubMed  Google Scholar 

  20. Yamada R, Kishi K, Terada M, Sonomura T, Sato M (1992) Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. In: Tobe T, Kaneda H, Okudaira M (eds) Primary liver cancer in Japan. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 259–271

    Google Scholar 

  21. Okada S, Maeba T, Maeta H, Tanaka S (1995) Effect of percutaneous transhepatic right branch of portal vein embolization on inducing human hepatocyte growth factor and liver function thereafter. Nippon Shokaki Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 28:1005–1012

    Google Scholar 

  22. Shalm L, Bax HR, Mensens BJ (1956) Atrophy of the liver after occlusion of the bile ducts or portal vein and compensatory hypertrophy of the unoccluded portion and its clinical importance. Gastroenterology 31:131–155

    Google Scholar 

  23. Tanaka H, Kinoshita H, Hirohashi K, Kubo S, Lee KC (1994) Increased safety by two-stage hepatectomy with preoperative portal vein embolization in rats. J Surg Res 57:687–692

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wakabayashi, H., Okada, S., Maeba, T. et al. Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: A preliminary report. Surg Today 27, 403–410 (1997). https://doi.org/10.1007/BF02385702

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02385702

Key Words

Navigation